Liquidia Corp Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Transfer Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc
Liquidia Corp
Pharmaceuticals
DE
2024
Description of Securities of the Company
Liquidia Corp
Pharmaceuticals
2024
Asset Transfer Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc
Liquidia Corp
Pharmaceuticals
DE
2023
Fourth Amendment to Promotion Agreement, dated as of March 10, 2023, by and between Liquidia PAH, LLC and Sandoz Inc
Liquidia Corp
Pharmaceuticals
NY
2023
Liquidia Corporation 2022 Inducement Plan
Liquidia Corp
Pharmaceuticals
DE
2022
Standstill Agreement, dated as of April 13, 2021, by and among Liquidia Corporation and Caligan Partners LP
Liquidia Corp
Pharmaceuticals
DE
2021
Description of Securities of the Company
Liquidia Corp
Pharmaceuticals
2021
First Amendment to Promotion Agreement, effective as of May 8, 2020, by and between RareGen, LLC and Sandoz Inc
Liquidia Corp
Pharmaceuticals
NY
2020
Promotion Agreement, dated as of August 1, 2018, by and between RareGen, LLC and Sandoz Inc
Liquidia Corp
Pharmaceuticals
DE
2020
Form of Lock-Up Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc. and each of the RareGen members party thereto
Liquidia Corp
Pharmaceuticals
2020
Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Eshelman Ventures, LLC and Fredric N. Eshelman, dated as of June 29, 2020
Liquidia Corp
Pharmaceuticals
2020
Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Canaan VIII L.P., dated as of June 29, 2020
Liquidia Corp
Pharmaceuticals
2020
Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Neal F. Fowler, dated as of June 29, 2020
Liquidia Corp
Pharmaceuticals
2020